Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
7.52
-0.25 (-3.22%)
At close: Oct 16, 2026, 4:00 PM EDT
7.41
-0.11 (-1.46%)
After-hours: Oct 16, 2026, 7:56 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $223.87 million as of October 16, 2026. It is the 20,091st most valuable company in the world and the 3,471st biggest in the United States. Its market cap has increased by 402.83% in one year.
Market Cap
223.87M
Enterprise Value
122.89M
1-Year Change
402.83%
Global Rank
Country Rank
#3,471 United States
Category
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $223.87M, an increase of 12.39%. That is a compound annual growth rate of 4.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 223.87M | 448.01% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 237.63M |
| Immuneering | 232.26M |
| SAB Biotherapeutics | 230.20M |
| BridgeBio Oncology Therapeutics | 226.09M |
| Lexeo Therapeutics | 216.59M |
| Vogenx | 215.84M |
| Fate Therapeutics | 214.48M |
| Greenwich LifeSciences | 213.57M |